Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 31, 2018Journal of Clinical MedicineOpen Access

New Directions for SMA Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SMSonia Messina

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sonia Messina (2018) studied this question.

synapsesocial.com/papers/6a9a4e26352e687f024d538ehttps://doi.org/10.3390/jcm7090251
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Natural history of infantile‐onset spinal muscular atrophy2017 · 416 citations
  2. 2Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset2016 · 62 citations
  3. 3CK‐2127107 amplifies skeletal muscle response to nerve activation in humans2017 · 72 citations
  4. 4Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study2019 · 648 citations
  5. 5Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy2018 · 1,473 citations